slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 35,551-35,580
Pages 3,683
Rows per page 30
Component
35,551-35,580 of 110,471
04
This slide functions as a 'short-seller' research note, highlighting negative sentiment from former employees and questioning the validity of corporate PR.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Villain Critique2 hits
14
Includes specific references to legal case 'Cooper v. Skillz, Inc.' and footnotes.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction2 hits
03
The slide uses a narrative structure to link historical missed revenue projections with specific instances of paid influencer marketing and suspicious trading activity by MMCAP International.POET Technologies Inc. (POET) · Wolfpack Research
Research note Short seller Beat · The Monster2 hits
01
This is the first page of an 11-page research note by Wolfpack Research.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Situation & Context2 hits
02
This page is a continuation of a research note, focusing on specific financial liabilities and asset quality issues.B. Riley Financial, Inc. (RILY) · Wolfpack Research
Research note Short seller Beat · Problem2 hits
94
The slide uses direct quotes from industry experts to build a case against the subject company's business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
134
The slide uses a Q&A format to document expert testimony regarding potential kickbacks and regulatory circumvention.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
152
The slide uses direct quotes from industry experts to build a case against TransMedics' business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
162
The slide uses a Q&A format to present expert testimony regarding potential misuse of medical devices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
183
The slide uses direct quotes from a transplant surgeon to expose potential malpractice or dangerous usage patterns.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
196
The slide uses direct quotes from a transplant surgeon to validate the claim of incompetence and poor operational performance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
199
The slide uses a Q&A format to present qualitative evidence of operational failures and reputational damage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
201
The slide uses a Q&A format to build a narrative of malpractice and dishonesty.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
244
The slide uses a narrative structure to expose operational risks and employee dissatisfaction.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
274
The slide uses Q&A transcripts to highlight a shift away from OCS technology in high-volume transplant centers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
320
The slide uses direct quotes from a consultation call to highlight the competitive threat of NRP to TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
323
The slide uses a 'canary in the coal mine' metaphor to frame the loss of a major customer as a leading indicator of broader market share erosion.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
327
The slide uses direct quotes from former employees to build a case for corporate malfeasance and product failure.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
71
Uses Q&A format to present primary source interview data.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
90
The slide uses expert quotes to undermine the technical viability of the competitor's product.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction2 hits
102
Uses Q&A format to present expert testimony as evidence of operational failure.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
103
Uses Q&A format to frame expert testimony as a critique of the company's core technology.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
113
Uses transcript excerpts to build a case for management's over-reliance on margin narrative.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
123
Uses red dashed boxes to highlight specific keywords in job descriptions that contradict the R&D classification.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
127
The slide uses direct quotes and SEC filing excerpts to demonstrate a pattern of inconsistent financial reporting by the CFO.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
167
The slide uses a Q&A format to highlight operational failures.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
175
The slide uses quotes from former employees to undermine the company's growth narrative.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
221
Uses red boxes to highlight specific text in the SEC correspondence.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
225
Uses direct quotes from regulatory filings and news articles to establish a link between sanctioned individuals and current investment control.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits
227
The slide uses Q&A format to highlight discrepancies between official disclosures and internal reality.Twist Bioscience (TWST) · Scorpion Capital
Activist deck Short seller 2 hits